ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,317Medicare Part D Prescriptions Filled, Including Refills

Rank: 56 out of 1290

$561K Total Retail Price of All Prescriptions

Rank: 162 out of 1290

581 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
80% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 581 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

9% of this provider’s 581 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 8,319 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $94 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 621 501 1 1
OMEPRAZOLE 441 331 2 2
LEVOTHYROXINE SODIUM 377 289 3 4
AMLODIPINE BESYLATE 351 301 4 3
METFORMIN HCL 325 240 5 10
LISINOPRIL 307 214 6 5
ZOLPIDEM TARTRATE 232 152 7 15
HYDROCHLOROTHIAZIDE 229 158 8 20
METOPROLOL TARTRATE 202 165 9 7
ATENOLOL 181 150 10 18
GABAPENTIN 180 113 11 8
MELOXICAM 177 127 12 31
FUROSEMIDE 156 135 13 9
AZITHROMYCIN 154 103 14 61
RANITIDINE HCL 137 86 15 49
GLIMEPIRIDE 136 123 16 57
TRAMADOL HCL 136 94 16 25
METOPROLOL SUCCINATE 127 87 18 14
LISINOPRIL-HYDROCHLOROTHIAZIDE 120 91 19 92
LOVASTATIN 111 83 20 45
ENALAPRIL MALEATE 102 75 21 62
ATORVASTATIN CALCIUM 101 71 22 23
DIOVAN HCT 98 78 23 112
WARFARIN SODIUM 97 81 24 22
HYDROCODONE-ACETAMINOPHEN 97 75 S3 24 6
CIPROFLOXACIN HCL 94 60 26 46
CLOPIDOGREL 94 81 26 24
PLAVIX 89 80 28 32
GLIPIZIDE 87 72 29 81
CARVEDILOL 85 82 30 12
POTASSIUM CHLORIDE 84 70 31 35
CRESTOR 83 56 32 17
LOSARTAN POTASSIUM 83 78 32 19
ALENDRONATE SODIUM 81 70 34 39
NEXIUM 81 46 34 34
IBUPROFEN 80 54 36 74
PANTOPRAZOLE SODIUM 79 45 37 48
ALLOPURINOL 77 71 38 60
PRAVASTATIN SODIUM 77 74 38 42
CLONIDINE HCL 77 64 38 66
FLUTICASONE PROPIONATE 73 46 41 26
NABUMETONE 71 45 42 312
AMLODIPINE BESYLATE-BENAZEPRIL 71 65 42 166
INSULIN SYRINGE 69 57 44 76
ALPRAZOLAM 69 44 44 47
LOSARTAN-HYDROCHLOROTHIAZIDE 68 52 46 106
TAMSULOSIN HCL 66 50 47 11
SERTRALINE HCL 62 34 48 36
PREDNISONE 61 33 49 21
LANTUS 61 48 49 67
ADVAIR DISKUS 57 34 51 37
DONEPEZIL HCL 56 55 52 13
LANTUS SOLOSTAR 55 47 53 88
MECLIZINE HCL 54 45 54 159
METHYLPREDNISOLONE 54 32 54 101
DIOVAN 54 45 54 53
GEMFIBROZIL 53 27 57 210
ISOSORBIDE MONONITRATE ER 52 51 58 58
SYNTHROID 52 48 58 28
DIGOXIN 50 37 60 51
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 15, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.